Evidence map›Paper›PMID 17917015›Full record

ArticleImmunologic research2007

TACI, isotype switching, CVID and IgAD.

Emanuela Castigli, Raif S Geha

Abstract read
PubMed Publisher
In one paragraph

Article in Immunologic research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Re-evaluation of the contribution ofJournal of human immunity · 2025
    Article
  3. Review
  4. Article
  5. Innate Mechanisms in Selective IgA Deficiency.Frontiers in immunology · 2021
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Innate control of B cell responses.Trends in immunology · 2011
    Review
  11. Article
  12. Common variable immunodeficiency: etiological and treatment issues.International archives of allergy and immunology · 2009
    Review
  13. Common variable immunodeficiency.American journal of rhinology & allergy
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Emanuela CastigliDivision of Immunology, Children's Hospital, Department of Pediatrics, Harvard Medical School, One Blackfan Circle, Boston, MA 02115, USA. emanuela.castigli@childrens.harvard.edu
Raif S Geha
Boston Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common Variable Immunodeficiency (CVID) is the most prevalent human primary immunodeficiency requiring medical attention. Until recently the only known genetic defect specific to CVID was ICOS deficiency that accounts for about 1% of the patients analyzed. Mutations in the TNFR family member TACI (transmembrane activator and calcium-modulator and cyclophilin ligand interactor), which mediates isotype switching in B cells, were found to be present in 5% of patients with CVID. Mutations in TACI were also found in relatives of patients with CVID who suffered from IgA deficiency (IgAD) as well as in a patient with isolated IgAD. In the majority of patients described to date only one TACI allele is mutated, showing an autosomal dominant transmission of the disease. B cells from individuals with TACI mutations did not produce IgG and IgA in response to the TACI ligand, APRIL (a proliferation-inducing ligand), probably reflecting impaired isotype switching. These results suggest that TACI mutations can lead to CVID.

Indexed as

Immunoglobulin Class SwitchingB-Cell Activating FactorB-Cell Activation Factor ReceptorB-LymphocytesCommon Variable ImmunodeficiencyHumansIgA DeficiencyImmunoglobulin IsotypesMutationTransmembrane Activator and CAML Interactor ProteinTumor Necrosis Factor Ligand Superfamily Member 13B-Cell Activating FactorB-Cell Activation Factor ReceptorImmunoglobulin IsotypesTNFRSF13B protein, humanTNFSF13B protein, humanTransmembrane Activator and CAML Interactor ProteinTumor Necrosis Factor Ligand Superfamily Member 13

Identifiers

PMID17917015
OpenAlexW2057866913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.